Answer
In adults, ranibizumab (Lucentis) can cause transient increases in intraocular pressure within 60 minutes of injection and sustained increases; intraocular pressure and optic nerve head perfusion must be monitored and managed appropriately.
Sources for this answer
- Lucentis 10 mg/ml solution for injectionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 33Document updated
Sources checked